Clinical Trial Update: A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety trial of adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED